Skip to main content
. 2020 Aug 26;10(9):1241. doi: 10.3390/biom10091241

Table 1.

Plasma glucose and insulin levels, as well as homeostatic model assessment for insulin resistance (HOMA-IR), after chronic cannabidiol (CBD) administration in rats fed standard (control group) and high-fat diets (HFD). The data are expressed as mean values ± SD, n = 10 in each group. a p < 0.05 significant difference: control group vs. examined group; b p < 0.05 significant difference: HFD vs. HFD + CBD.

Control CBD HFD HFD + CBD
Glucose (mg/dL) 105 ± 8 93 ± 7 a 94 ± 7 100 ± 6
Insulin (μg/mL) 0.65 ± 0.12 0.70 ± 0.18 1.24 ± 0.19 a 0.95 ± 0.25 a,b
HOMA-IR 3.84 ± 0.25 3.57 ± 0.77 6.46 ± 1.40 a 5.62 ± 1.56 a